D-1172-2023 Class III Terminated
FDA drug recall D-1172-2023 was initiated by SUN PHARMACEUTICAL INDUSTRIES INC on Sep 7, 2023 and is designated Class III. Reason for recall: Subpotent: Out of Specification result observed for low assay The recall status is terminated (terminated Feb 13, 2024). Affected quantity: 69,707 cartons.
Recall details
- Product Type
- Drugs
- Report Date
- Sep 27, 2023
- Initiation Date
- Sep 7, 2023
- Termination Date
- Feb 13, 2024
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 69,707 cartons
Product description
Cequa (cyclosporine ophthalmic solution) 0.09%, 60 Single-Use Vials (6 pouches x 10 single-use vials (0.25 mL each)), Rx only, Manufactured for Sun Pharma Global FZE by: Laboratoire Unither, Coutances, France NDC 47335-506-96
Reason for recall
Subpotent: Out of Specification result observed for low assay
Distribution pattern
Nationwide wide in the USA
Code information
Lot# 10026, Lot 10027, Exp. 09/2023.
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-1172-2023
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026